Cutaneous clinico-pathological findings in three covid-19-positive patients observed in the metropolitan area of Milan, Italy by R. Gianotti et al.
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The novel coronavirus SARS-CoV-2/COVID-19 is ra-
pidly and dramatically spreading throughout the world. 
We describe the clinical and histopathological features of 
3 Italian patients with different cutaneous presentations 
of COVID-19 infection, observed and followed at the 
University of Milan. 
CASE REPORTS
Case 1. A 59-year-old woman was admitted to the intensive care 
unit (ICU) at the University of Milan with bilateral interstitial 
pneumonia. Three days after admission, she developed widespread 
erythematous macules on arms, trunk and lower limbs (Fig. 1 A-C) 
that spontaneously improved within 5 days. C-reactive protein was 
12 mg/l. Reverse transcriptase (RT)-PCR for COVID-19 virus was 
positive. Treatment was started with lopinavir-ritonavir, heparin 
and levofloxacin. She is currently recovering. 
Case 2. An 89-year-old woman was suffering from fever and 
cough of one-week duration. An exanthem on the trunk and arms 
was observed on admission at ICU (Fig. 1 D,E). Laboratory tests 
revealed mild increase in fibrinogen and transaminases. RT-PCR 
was positive for COVID-19 virus. Ceftriaxone and azithromycin 
were started. The exanthem improved spontaneously 8 days later. 
Case 3. A 57-year-old man in good general health acutely develo-
ped a widespread pruritic eruption of erythematous macules and 
papules (Fig. 1 F,G), followed two days later by fever, headache, 
cough and arthralgias. RT-PCR for COVID-19 virus was positive. 
Treatment with levofloxacin and hydroxychloroquine was started. 
It was suggested that the patient go home for quarantine. Ten days 
after the appearance of the rash, skin lesions reduced in number 
and severity without therapy. 
Histopathological examinations
Histopathology of the leg in Case 1 showed a superficial perivas-
cular dermatitis with slight lymphocytic exocytosis. In the mid 
dermis a small thrombus in a vessel was present. Swollen throm-
bosed vessels with neutrophils, eosinophils and nuclear debris 
were patchy distributed in the dermis (Fig. 2 A-C). 
Histopathology of the back in Case 2 showed a superficial and 
deep perivascular dermatitis with cuffs of lymphocytes surroun-
ding blood vessels in a vasculitic pattern (Fig. 2D). In the mid 
dermis extravasated red blood cells from damaged vessels were 
visible (Fig. 2E). 
Histopathology of the back in Case 3 showed a superficial 
perivascular vesicular dermatitis. Focal acantholytic suprabasal 
clefts, dyskeratotic and ballooning herpes-like keratinocytes were 
observed. A patchy band-like infiltration with occasional necrotic 
keratinocytes and minimal lymphocytic satellitosis were present. 
In the dermis the vessels were swollen, with dense lymphocyte 
infiltration, mixed with rare eosinophils. Within the epidermis a 
nest of Langerhans cells were also observed (Fig. 2 F-H).
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Fig. 1. Case 1 (A). Erythema on 
the abdomen. (B). Erythematous 
macules on a leg. (C). Diffuse 
erythematous macules on a 
forearm. Case 2 (D). Erythema 
on the chest and abdomen. (E). 
Close up image demonstrating 
erythematous plaques made up 
of tiny papules. Case 3 (F, G). 
Widespread erythematous crusted 
papules; some of them are erosive.
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documented cutaneous rash in 20% of patients, most 
commonly as “erythematous rash” (1). Other cutaneous 
manifestations include urticaria (1), papules and vesicles 
(1) and a “dengue-like” rash (2). 
The clinical and histopathological differential diag-
nosis of an exanthematous eruption most commonly 
includes drug eruptions and viral infections. Positive 
COVID-19 virus RT-PCRs in all our patients strongly 
suggests an exanthem associated with a viral infection. 
The histopathological picture observed in Cases 1 and 2 
is consistent with that of a viral exanthem. However, the 
finding of early microthrombi in Case 1 is significant, as 
autopsy reports from COVID-19-infected patients have 
shown hyaline thrombi in microvessels of the lungs (3). 
Furthermore, one of us (RG) had the opportunity to study 
a second case of disseminated intravascular coagulation-
like lesions in a COVID-19-positive patient (in press). 
Very recently, a paper (currently in press), reported 
severe thrombosis of the cutaneous vascular plexus in 5 
patients with superimposable histopathological features 
of our Case 1 (4).
Skin specimen from Case 2 did not show thrombi 
in small vessels, but features present in a lymphocytic 
vasculitis that are similar to those observed in throm-
bophilic arteritis induced by blood immune complexes 
that activate cytokines recruiting eosinophils and cyto-
toxic T cells (5). 
The histopathology observed in Case 3 has features re-
miniscent of transient acantholytic dermatosis (Grover’s 
disease), with ballooning multinucleated cells. We do not 
think it is a fortuitous concomitant disease because two 
of us (RG and SV) observed a second case of Grover’s 
disease in a COVID-19- positive patient (in press). These 
overlapping features, mimicking a herpes infection, 
have already been described in patients with simulta-
neous Grover’s and Kaposi’s varicelliform eruption 
(6). An interface dermatitis with necrotic keratinocytes 
surrounded by lymphocytes may suggest that the virus 
induces a cytokine cascade activation of cytotoxic and 
NK lymphocytes which in turn damage keratinocytes. 
Finally, nests of Langerhans cells are well known to be 
present in other viral-induced skin dermatitis, such as 
pityriasis rosea (7).
We think that the finding of viral particles present in 
the cutaneous blood vessels in patients with COVID-19 
infection (4) could implicate a possible viral interaction 
also with the keratinocytes, inducing a spectrum of dif-
ferent clinical manifestations. 
The authors have no conflicts of interest to declare.
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Fig. 2. Case 1. (A) Superficial 
perivascular dermatitis with mild 
spongiosis and a small thrombus 
in the mid dermis (encircled). (B) 
Vasculitis with nuclear debris and 
a small thrombus (encircled). 
(C) High magnification of a 
small thrombized vessel. Case 
2: (D) Superficial perivascular 
dermatitis with lymphocytic 
vasculitis in mid dermis. (E) 
Extravasated red blood cells due 
to endothelial damage.  Case 
3: (F) Superficial perivascular 
and vesicular dermatitis with 
patchy band-like infiltration. 
(G)  Dyskeratotic, ballooning 
and necrotic keratinocytes with 
lymphocytic exocytosis. (H) 
Nest of Langerhans cells within 
the epidermis.
